VanEck's concentrated 25-stock approach offers higher individual company exposure, while Invesco's broader 251-position ...

Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3% ...

PBE concentrates on 31 companies and offers a higher dividend yield, while IBBQ spreads risk across 251 holdings at a ...

Harlan Robins spent years as the co-founder and chief scientific officer of Adaptive Biotechnologies, helping build massive datasets to decode… Read More ...

Werewolf Therapeutics, Inc. HOWL was one of the market’s biggest pre-market movers on Friday after announcing a merger with ...

ROCHESTER, N.Y. (WROC) — In Henrietta, the Archimedes Center held a showcase for a new, fully equipped biotech accelerator ...

Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering ...

Virtus Biotech ETF (BBP) gets a buy rating: equal-weight, quarterly rebalanced exposure to FDA-approved biotechs, deal ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 ...

Cellares Corp., among the Bay Area's fastest-growing companies because of its promise to accelerate manufacturing of ...

North Carolina’s life sciences industry has grown to include 860 companies statewide that employ 76,000 North Carolinians, ...